Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Atosiban Genfarma

Atosiban Genfarma :
Type Medicine registered
Originator Tractocile 37.5mg
Agent Alfamed
Distributor Alfamed
Laboratory Genfarma Laboratorio
Manufacturer Genfarma Laboratorio S.L.
Manufacturing Type G
Origin Spain
ATC G02CX01

Your comment will appear shortly after approval

Atosiban Genfarma :

Revision Date : 31/07/2013


Effect Frequency
Dizziness Common
Dyspnoea (dyspnea) Not known
Headache Common
Hot flush Common
Hyperglycaemia Common
Hypersensitivity Rare
Hypotension Common
Injection site reaction Common
Insomnia Uncommon
Nausea Very Common
Pruritus Uncommon
Pulmonary oedema Not known
Pyrexia Uncommon
Skin rash Uncommon
Tachycardia Common
Uterine atony Rare
Uterine bleeding (Uterine haemorrhage) Rare
Vomiting Common

Different Units By MoH Code

Atosiban Genfarma  MoH 2063596 :
Form Concentrate for solution for infusion
Packaging Bottle (Glass)
Package Size 1x5ml
Strength 37.5mg
Stratum N/A
NSSF ✘
Quarantine ✘
Submission date 23/04/2019
Registration Year 18/07/2019
Pending Year 18/07/2019
Pending Reason Incomplete file


Price Comparison

● Country: Spain
● Package Size: 1x5 ml
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info